|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$2.81 |
$2.91 |
$2.81 |
$2.85 |
9.80K | 04/23/2024 |
$2.85 |
$2.88 |
$2.85 |
$2.88 |
4.50K | 04/24/2024 |
$2.87 |
$3.16 |
$2.87 |
$2.90 |
8.40K | 04/25/2024 |
$2.86 |
$2.93 |
$2.86 |
$2.93 |
2.60K | 04/26/2024 |
$2.80 |
$3.13 |
$2.77 |
$2.90 |
3.80K |
|
Acasti Pharma is a biopharmaceutical company that is focused on developing and commercializing products for rare and orphan diseases by using its drug delivery technologies. Co.'s primary drug candidate, GTX-104, is an IV formulation of nimodipine designed to treat subarachnoid hemorrhage, a rare brain disorder. Co.'s other drug candidates are: GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia, an orphan pediatric genetic neurodegenerative disorder in young children; and GTX-101, which is a topical bioadhesive film-forming bupivacaine spray for Postherpetic Neuralgia, which causes debilitating pain following infection by the shingles virus. | |
|
Acasti Pharma (ACST) has the following price history information. Looking back at ACST historical stock prices for the last five trading days, on April 22, 2024, ACST opened at $2.81, traded as high as $2.91 and as low as $2.81, and closed at $2.85. Trading volume was a total of 9.80K shares. On April 23, 2024, ACST opened at $2.85, traded as high as $2.88 and as low as $2.85, and closed at $2.88. Trading volume was a total of 4.50K shares. On April 24, 2024, ACST opened at $2.87, traded as high as $3.16 and as low as $2.87, and closed at $2.90. Trading volume was a total of 8.40K shares. On April 25, 2024, ACST opened at $2.86, traded as high as $2.93 and as low as $2.86, and closed at $2.93. Trading volume was a total of 2.60K shares. On April 26, 2024, ACST opened at $2.80, traded as high as $3.13 and as low as $2.77, and closed at $2.90. Trading volume was a total of 3.80K shares.
ACST Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acasti Pharma shares, starting with a $10,000 purchase of ACST, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/30/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$31,900.80 |
|
End price/share: |
$2.90 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.99% |
|
Average Annual Total Return: |
-60.58% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.91 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $2.85 | 04/23/2024 | $2.88 | 04/24/2024 | $2.90 | 04/25/2024 | $2.93 | 04/26/2024 | $2.90 |
|
|